drugset / Trial / NCT05390021

PET/MRI in Endometrial Cancer

NCT05390021

NaSingle-groupOpen-labelDiagnostic

Summary

This study is investigating if positron emission tomography (PET)/Magnetic resonance imaging (MRI) is more effective than the currently used imaging modalities (computed tomography \[CT\], or PET/CT) for high-risk endometrial cancer. The name of the intervention involved in this study is: Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)

Timeline

Start
2024-03-30
Primary completion
2025-02-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Background 18F-FDG Diagnostic / imaging agent